Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
A Sundqvist, A Zieba, E Vasilaki, C Herrera Hidalgo, O Söderberg, D Koinuma, K Miyazono, C-H Heldin, U Landegren, P Ten Dijke, H van Dam
Index: Oncogene 32(31) , 3606-15, (2013)
Full Text: HTML
Abstract
Deregulation of the transforming growth factor β (TGFβ) signal transduction cascade is functionally linked to cancer. In early phases, TGFβ acts as a tumor suppressor by inhibiting tumor cell proliferation, whereas in late phases, it can act as a tumor promoter by stimulating tumor cell invasion and metastasis. Smad transcriptional effectors mediate TGFβ responses, but relatively little is known about the Smad-containing complexes that are important for epithelial-mesenchymal transition and invasion. In this study, we have tested the hypothesis that specific members of the AP-1 transcription factor family determine TGFβ signaling specificity in breast cancer cell invasion. Using a 3D model of collagen-embedded spheroids of MCF10A-MII premalignant human breast cancer cells, we identified the AP-1 transcription factor components c-Jun, JunB, c-Fos and Fra1 as essential factors for TGFβ-induced invasion and found that various mesenchymal and invasion-associated TGFβ-induced genes are co-regulated by these proteins. In situ proximity ligation assays showed that TGFβ signaling not only induces complexes between Smad3 and Smad4 in the nucleus but also complexes between Smad2/3 and Fra1, whereas complexes between Smad3, c-Jun and JunB could already be detected before TGFβ stimulation. Finally, chromatin immunoprecipitations showed that c-Jun, JunB and Fra1, but not c-Fos, are required for TGFβ-induced binding of Smad2/3 to the mmp-10 and pai-1 promoters. Together these results suggest that in particular formation of Smad2/3-Fra1 complexes may reflect activation of the Smad/AP-1-dependent TGFβ-induced invasion program.
Related Compounds
Related Articles:
2014-09-26
[J. Chromatogr. A. 1361 , 265-76, (2014)]
2015-02-01
[Biochim. Biophys. Acta 1848(2) , 712-20, (2014)]
2014-08-22
[J. Chromatogr. A. 1356 , 105-16, (2014)]
2014-01-01
[Int. Arch. Allergy Immunol. 165(2) , 83-90, (2014)]
2015-04-10
[Int. J. Pharm. 483(1-2) , 131-41, (2015)]